Search results for

In May, North Korean leaders hinted to a visiting U.S scholar that they're willing to resume negotiations with the United States on nuclear arms. But if those talks are revived, North Korea wants to focus on mutual steps toward a denuclearized Korean peninsula. The Bush administration has said repeatedly it doesn't want to depart from six-way nuclear talks.

North Korea has test-fired a new type of tactical guided weapon designed to boost its nuclear fighting capability, state media reported Sunday, days after it passed its biggest state anniversary.

Ali Kushayb has pleaded not guilty to 31 counts of war crimes and crimes against humanity in connection to atrocities committed in the Darfur region of Sudan.

Israeli police entered the compound in the Old City to secure the way for Jewish visitors to the holy site, fueling clashes that left 17 Palestinians wounded.

The White House has faced questions and criticism in its handling of the hunting accident involving Vice President Dick Cheney. The victim in the mishap, lawyer Harry Whittington, suffered a minor heart attack Tuesday. Cheney's office subsequently issued its first statement on the matter.

New York Times reporter Judith Miller tells a grand jury what she knows about how CIA operative Valerie Plame's name was revealed to the public. The Times says Miller's source was Lewis Libby, chief of staff to Vice President Cheney.

Peasants relocated to make room for a reservoir in northern China's Hebei province claim local leaders pocketed more than $7 million in compensation funds owed to them. Those who tried to organize a recall vote were bribed, beaten or jailed into submission. The case typifies recent rural protests.

Black is being remembered for his commentary on a wide range of issues — from Thanksgiving turkeys to children's names to the Supreme Court — from the perspective of a Western farmer and rancher.

In an attempt to curb high inflation, the Federal Reserve is expected this week to begin raising interest rates for the first time in three years.

The antiviral pill molnupiravir was authorized and distributed by the government late last year. But it's not doctors' first choice of treatment, except for a narrow slice of patients.